RT Journal Article
SR Electronic
T1 Effects of repeated vaccination and vaccine formulation on the induction of broadly neutralizing antibody responses against influenza A virus in children
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.03.21261495
DO 10.1101/2021.08.03.21261495
A1 Yegorov, Sergey
A1 Celeste, Daniel B.
A1 Gomes, Kimberly Braz
A1 Ang, Jann C.
A1 Vandenhof, Colin
A1 Wang, Joanne
A1 Rybkina, Ksenia
A1 Tsui, Vanessa
A1 Loeb, Mark
A1 Miller, Matthew S.
YR 2021
UL http://medrxiv.org/content/early/2021/08/05/2021.08.03.21261495.abstract
AB The induction of broadly neutralizing antibodies (bNAbs) that target the hemagglutinin stalk domain is a promising strategy for the development of “universal” influenza virus vaccines. bNAbs can be boosted in adults by sequential exposure to heterosubtypic viruses through natural infection or vaccination. However, little is known about if/how bNAbs are induced by vaccination in more immunologically naive children. Here, we describe the impact of repeated seasonal influenza vaccination and vaccine type on induction of bNAbs in a well-characterized paediatric cohort enrolled in a series of randomized control trials of seasonal influenza vaccination. Repeated seasonal vaccination resulted in significant boosting of a durable bNAb response. Boosting of serological bNAbs titers was comparable within inactivated and live attenuated (LAIV) vaccinees and declined with age. These data provide new insights into vaccine-elicited bNAb induction in children, which has important implications for the design of “universal” influenza vaccine modalities in this critical population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by a project grant from the Canadian Institutes of Health Research (CIHR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study procedures were approved by the McMaster University Research Ethics Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is provided in the manuscript